Eagle Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) announced today that Scott Tarriff, President and Chief Executive Officer, and David Riggs, Chief Financial Officer, will present at the Cantor Fitzgerald Inaugural Healthcare Conference as follows:

The presentation will be webcast live at the aforementioned time, and archived for 90 days thereafter, via the Company’s website at www.eagleus.com, under the Investors Section or click here.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150630005157/en/

In-Site Communications, Inc.
Lisa M. Wilson
President
212-452-2793

Source: Eagle Pharmaceuticals, Inc.

You May Also Be Interested In

• Cantor Fitzgerald Starts Enhanced Group Inc. (ENHA) at Overweight
• Allied Critical Metals Files and Mails Management Information Circular and Announces Director Nominees
• CU SoCal Donates More Than $340,000 to Strengthen Southern California Communities